Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Testing effectiveness (Phase 2)UnknownNCT00795613
What this trial is testing

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Who this might be right for
HODGKIN LYMPHOMA
Ospedale Santa Croce-Carle Cuneo 450
Early research (Phase 1)Looking for participantsNCT05892393
What this trial is testing

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
Robert Flavell, MD, PhD 20
Not applicableTemporarily Not AvailableNCT06980519
What this trial is testing

MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Who this might be right for
CancerSolid TumorSolid Tumor Cancer+3 more
Monopar Therapeutics
Not applicableStudy completedNCT05680675
What this trial is testing

Dual-Tracer Theranostic PET

Who this might be right for
Neuroendocrine TumorsProstate Cancer
University of Utah 50
Not applicableStudy completedNCT02023996
What this trial is testing

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Who this might be right for
Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center 42
Not applicableLooking for participantsNCT06708910
What this trial is testing

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Who this might be right for
HER2 Positive Breast Carcinoma
Heinrich-Heine University, Duesseldorf 460
Testing effectiveness (Phase 2)Study completedNCT00257023
What this trial is testing

An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 52
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Early research (Phase 1)Looking for participantsNCT04332588
What this trial is testing

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Who this might be right for
HER2-positive Breast Cancer
University of Alabama at Birmingham 25
Early research (Phase 1)Active Not RecruitingNCT05245006
What this trial is testing

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Robert Flavell, MD, PhD 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04316117
What this trial is testing

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more
ECOG-ACRIN Cancer Research Group 138
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Not applicableLooking for participantsNCT07362225
What this trial is testing

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Who this might be right for
Polycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more
MPN Research Foundation 5,000
Not applicableUnknownNCT05535621
What this trial is testing

68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients

Who this might be right for
HER2-Positive Cancer
Tongji Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03831711
What this trial is testing

68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

Who this might be right for
Breast CarcinomaEstrogen Receptor Positive
Andrei Iagaru 5
Not applicableWithdrawnNCT01789892
What this trial is testing

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center
Not applicableWithdrawnNCT01714128
What this trial is testing

FES-PET for Patients Treated on NCI Protocol 8762

Who this might be right for
Breast Cancer
Washington University School of Medicine
Post-approval studies (Phase 4)Looking for participantsNCT06072807
What this trial is testing

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Weill Medical College of Cornell University 20
Very early researchLooking for participantsNCT06638034
What this trial is testing

Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

Who this might be right for
FAP- Expressing Positive TumorsRGD- Expressing Positive Tumors
Peking Union Medical College Hospital 15
Next Page